GSTM1 and chronic myelogenous leukemia, BCR-ABL1 positive: The proportion of CML cancer attributable to the interaction of smoking and GSTM1 null was 42% and was 39%, 13% for GSTT1 null and GSTP1 M*, respectively (Table 4).